Researchers said 'there is likely to be a substantial burden of undiagnosed patients' as they did not see a rebound in diagnoses after restrictions were lifted.
It means many patients who might have the disease have not been seen by their GP or been reviewed by a hospital specialist, with cases not having jumped up above pre-2020 levels until April this year, they said. The Daily Mail
See also:
- Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY (open access) The Lancet Rheumatology
- The impact of COVID-19 on care of early inflammatory arthritis in the UK (open access) The Lancet Rheumatology
No comments:
Post a Comment